Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 340

1.

The FKH domain in FOXP3 mRNA frequently contains mutations in hepatocellular carcinoma that influence the subcellular localization and functions of FOXP3.

Ren J, Liu Y, Wang S, Wang Y, Li W, Chen S, Cui D, Yang S, Li MY, Feng B, Lai PBS, Chen GG.

J Biol Chem. 2020 Mar 20. pii: jbc.RA120.012518. doi: 10.1074/jbc.RA120.012518. [Epub ahead of print]

2.

Positive Hepatitis B Core Antibody Is Associated With Cirrhosis and Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease.

Chan TT, Chan WK, Wong GL, Chan AW, Nik Mustapha NR, Chan SL, Chong CC, Mahadeva S, Shu SS, Lai PB, Chan HL, Wong VW.

Am J Gastroenterol. 2020 Mar 9. doi: 10.14309/ajg.0000000000000588. [Epub ahead of print]

PMID:
32149781
3.

Prospective double-blinded randomized controlled trial of Microwave versus RadioFrequency Ablation for hepatocellular carcinoma (McRFA trial).

Chong CCN, Lee KF, Cheung SYS, Chu CCM, Fong AKW, Wong J, Hui JWY, Fung AKY, Lok HT, Lo EYJ, Chan SL, Yu SCH, Ng KKC, Lai PBS.

HPB (Oxford). 2020 Feb 8. pii: S1365-182X(20)30023-X. doi: 10.1016/j.hpb.2020.01.008. [Epub ahead of print]

PMID:
32044268
4.

ZBP-89 negatively regulates self-renewal of liver cancer stem cells via suppression of Notch1 signaling pathway.

Wang N, Li MY, Liu Y, Yu J, Ren J, Zheng Z, Wang S, Yang S, Yang SL, Liu LP, Hu BG, Chong CC, Merchant JL, Lai PB, Chen GG.

Cancer Lett. 2020 Mar 1;472:70-80. doi: 10.1016/j.canlet.2019.12.026. Epub 2019 Dec 23.

PMID:
31874246
5.

The chances of hepatic resection curing hepatocellular carcinoma.

Cucchetti A, Zhong J, Berhane S, Toyoda H, Shi K, Tada T, Chong CCN, Xiang BD, Li LQ, Lai PBS, Ercolani G, Mazzaferro V, Kudo M, Cescon M, Pinna AD, Kumada T, Johnson PJ.

J Hepatol. 2020 Apr;72(4):711-717. doi: 10.1016/j.jhep.2019.11.016. Epub 2019 Nov 30.

PMID:
31790765
6.

Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas.

Ding X, He M, Chan AWH, Song QX, Sze SC, Chen H, Man MKH, Man K, Chan SL, Lai PBS, Wang X, Wong N.

Gastroenterology. 2019 Dec;157(6):1630-1645.e6. doi: 10.1053/j.gastro.2019.09.005. Epub 2019 Sep 24.

7.

Topically applied adipose-derived mesenchymal stem cell treatment in experimental focal cerebral ischemia.

Lam PK, Wang KKW, Chin DWC, Tong CSW, Wang Y, Lo KKY, Lai PBS, Ma H, Zheng VZY, Poon WS, Wong GKC.

J Clin Neurosci. 2020 Jan;71:226-233. doi: 10.1016/j.jocn.2019.08.051. Epub 2019 Aug 17.

PMID:
31431402
8.

Impact of Intermittent Pringle Maneuver on Long-Term Survival After Hepatectomy for Hepatocellular Carcinoma: Result from Two Combined Randomized Controlled Trials.

Lee KF, Chong CCN, Cheung SYS, Wong J, Fung AKY, Lok HT, Lai PBS.

World J Surg. 2019 Dec;43(12):3101-3109. doi: 10.1007/s00268-019-05130-8.

PMID:
31420724
9.

ER-residential Nogo-B accelerates NAFLD-associated HCC mediated by metabolic reprogramming of oxLDL lipophagy.

Tian Y, Yang B, Qiu W, Hao Y, Zhang Z, Yang B, Li N, Cheng S, Lin Z, Rui YC, Cheung OKW, Yang W, Wu WKK, Cheung YS, Lai PBS, Luo J, Sung JJY, Chen R, Wang HY, Cheng ASL, Yang P.

Nat Commun. 2019 Jul 29;10(1):3391. doi: 10.1038/s41467-019-11274-x.

10.

Robotic versus laparoscopic hepatectomy: application of the difficulty scoring system.

Chong CCN, Lok HT, Fung AKY, Fong AKW, Cheung YS, Wong J, Lee KF, Lai PBS.

Surg Endosc. 2020 May;34(5):2000-2006. doi: 10.1007/s00464-019-06976-8. Epub 2019 Jul 16.

PMID:
31312961
11.

A comparability study of immunohistochemical assays for PD-L1 expression in hepatocellular carcinoma.

Shi L, Zhang SJ, Chen J, Lu SX, Fan XJ, Tong JH, Chow C, Tin EK, Chan SL, Chong CC, Lai PB, To KF, Wong N, Chan AW.

Mod Pathol. 2019 Nov;32(11):1646-1656. doi: 10.1038/s41379-019-0307-8. Epub 2019 Jun 23.

PMID:
31231126
12.

Robotic cholecystectomy for duplicated gallbladder.

Fung AK, Fai Lee K, Cn Chong C, Lai PB.

Scott Med J. 2019 Aug;64(3):112-115. doi: 10.1177/0036933019853161. Epub 2019 May 29.

PMID:
31142212
13.

The ATP-binding cassette transporter ABCF1 is a hepatic oncofetal protein that promotes chemoresistance, EMT and cancer stemness in hepatocellular carcinoma.

Fung SW, Cheung PF, Yip CW, Ng LW, Cheung TT, Chong CC, Lee C, Lai PB, Chan AW, Tsao GS, Wong CH, Chan SL, Lo KW, Cheung ST.

Cancer Lett. 2019 Aug 10;457:98-109. doi: 10.1016/j.canlet.2019.05.010. Epub 2019 May 14.

14.

Targeting monocyte-intrinsic enhancer reprogramming improves immunotherapy efficacy in hepatocellular carcinoma.

Liu M, Zhou J, Liu X, Feng Y, Yang W, Wu F, Cheung OK, Sun H, Zeng X, Tang W, Mok MTS, Wong J, Yeung PC, Lai PBS, Chen Z, Jin H, Chen J, Chan SL, Chan AWH, To KF, Sung JJY, Chen M, Cheng AS.

Gut. 2020 Feb;69(2):365-379. doi: 10.1136/gutjnl-2018-317257. Epub 2019 May 10.

PMID:
31076403
15.

Correlations of health-related quality of life with serum inflammatory indicators IL-8 and mIBI in patients with hepatocellular carcinoma.

Li L, Chan SL, Mo F, Hui EP, Koh J, Chan AKC, Tang NLS, Lee KF, Lai PBS, Yu SCH, Yeo W.

Cancer Manag Res. 2019 Apr 4;11:2719-2727. doi: 10.2147/CMAR.S178482. eCollection 2019.

16.

Enhanced recovery after surgery for liver resection.

Chong CCN, Chung WY, Cheung YS, Fung AKY, Fong AKW, Lok HT, Wong J, Lee KF, Chan SKC, Lai PBS.

Hong Kong Med J. 2019 Apr;25(2):94-101. doi: 10.12809/hkmj187656. Epub 2019 Mar 27.

17.
18.

Multicentre validation of a clinical prognostic score integrating the systemic inflammatory response to the host for patients treated with curative-intent for colorectal liver metastases: The Liverpool score.

Dupré A, Berhane S, Chan AWH, Rivoire M, Chong CCN, Lai PBS, Cucchetti A, Poston GJ, Malik HZ, Johnson PJ.

Eur J Surg Oncol. 2019 Jun;45(6):999-1004. doi: 10.1016/j.ejso.2019.02.022. Epub 2019 Feb 21.

PMID:
30827803
19.

Orientation-aware plasma cell-free DNA fragmentation analysis in open chromatin regions informs tissue of origin.

Sun K, Jiang P, Cheng SH, Cheng THT, Wong J, Wong VWS, Ng SSM, Ma BBY, Leung TY, Chan SL, Mok TSK, Lai PBS, Chan HLY, Sun H, Chan KCA, Chiu RWK, Lo YMD.

Genome Res. 2019 Mar;29(3):418-427. doi: 10.1101/gr.242719.118.

20.

Genome-Wide Screening and Functional Analysis Identifies Tumor Suppressor Long Noncoding RNAs Epigenetically Silenced in Hepatocellular Carcinoma.

Xu F, Li CH, Wong CH, Chen GG, Lai PBS, Shao S, Chan SL, Chen Y.

Cancer Res. 2019 Apr 1;79(7):1305-1317. doi: 10.1158/0008-5472.CAN-18-1659. Epub 2019 Feb 4.

21.

Aberrant enhancer hypomethylation contributes to hepatic carcinogenesis through global transcriptional reprogramming.

Xiong L, Wu F, Wu Q, Xu L, Cheung OK, Kang W, Mok MT, Szeto LLM, Lun CY, Lung RW, Zhang J, Yu KH, Lee SD, Huang G, Wang CM, Liu J, Yu Z, Yu DY, Chou JL, Huang WH, Feng B, Cheung YS, Lai PB, Tan P, Wong N, Chan MW, Huang TH, Yip KY, Cheng AS, To KF.

Nat Commun. 2019 Jan 18;10(1):335. doi: 10.1038/s41467-018-08245-z.

22.

Cancer stem cells in hepatocellular carcinoma: an overview and promising therapeutic strategies.

Wang N, Wang S, Li MY, Hu BG, Liu LP, Yang SL, Yang S, Gong Z, Lai PBS, Chen GG.

Ther Adv Med Oncol. 2018 Dec 21;10:1758835918816287. doi: 10.1177/1758835918816287. eCollection 2018. Review.

23.

Homology-independent multiallelic disruption via CRISPR/Cas9-based knock-in yields distinct functional outcomes in human cells.

Zhang C, He X, Kwok YK, Wang F, Xue J, Zhao H, Suen KW, Wang CC, Ren J, Chen GG, Lai PBS, Li J, Xia Y, Chan AM, Chan WY, Feng B.

BMC Biol. 2018 Dec 28;16(1):151. doi: 10.1186/s12915-018-0616-2.

24.

An inflammatory-CCRK circuitry drives mTORC1-dependent metabolic and immunosuppressive reprogramming in obesity-associated hepatocellular carcinoma.

Sun H, Yang W, Tian Y, Zeng X, Zhou J, Mok MTS, Tang W, Feng Y, Xu L, Chan AWH, Tong JH, Cheung YS, Lai PBS, Wang HKS, Tsang SW, Chow KL, Hu M, Liu R, Huang L, Yang B, Yang P, To KF, Sung JJY, Wong GLH, Wong VWS, Cheng ASL.

Nat Commun. 2018 Dec 6;9(1):5214. doi: 10.1038/s41467-018-07402-8.

25.

Pattern of disease recurrence and its implications for postoperative surveillance after curative hepatectomy for hepatocellular carcinoma: experience from a single center.

Lee KF, Chong CCN, Fong AKW, Fung AKY, Lok HT, Cheung YS, Wong J, Lai PBS.

Hepatobiliary Surg Nutr. 2018 Oct;7(5):320-330. doi: 10.21037/hbsn.2018.03.17.

26.

Novel biomarkers GEP/ABCB5 regulate response to adjuvant transarterial chemoembolization after curative hepatectomy for hepatocellular carcinoma.

Chong CC, Cheung ST, Cheung YS, Chan AW, Chan SL, Yu SC, Lai PB.

Hepatobiliary Pancreat Dis Int. 2018 Dec;17(6):524-530. doi: 10.1016/j.hbpd.2018.10.003. Epub 2018 Oct 29.

PMID:
30413348
27.

Successful robotic extirpation of diaphragmatic seeding of hepatocellular carcinoma after previous rupture.

Lee KF, Lok HT, Fung AKY, Chong CCN, Cheung YS, Wong J, Lai PBS.

J Robot Surg. 2019 Jun;13(3):525-528. doi: 10.1007/s11701-018-0880-8. Epub 2018 Sep 29.

PMID:
30269251
28.

Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection.

Chan AWH, Zhong J, Berhane S, Toyoda H, Cucchetti A, Shi K, Tada T, Chong CCN, Xiang BD, Li LQ, Lai PBS, Mazzaferro V, García-Fiñana M, Kudo M, Kumada T, Roayaie S, Johnson PJ.

J Hepatol. 2018 Dec;69(6):1284-1293. doi: 10.1016/j.jhep.2018.08.027. Epub 2018 Sep 18.

29.

ID1-induced p16/IL6 axis activation contributes to the resistant of hepatocellular carcinoma cells to sorafenib.

Niu LL, Cheng CL, Li MY, Yang SL, Hu BG, Chong CCN, Chan SL, Ren J, Chen GG, Lai PBS.

Cell Death Dis. 2018 Aug 28;9(9):852. doi: 10.1038/s41419-018-0926-x.

30.

Targeting ZBP-89 for the treatment of hepatocellular carcinoma.

Wang N, Wang S, Yang SL, Liu LP, Li MY, Lai PBS, Chen GG.

Expert Opin Ther Targets. 2018 Oct;22(10):817-822. doi: 10.1080/14728222.2018.1516753. Epub 2018 Sep 6. Review.

PMID:
30142986
31.

Robot-assisted minimally invasive procedures for complicated biliary stone disease.

Lee KF, Fung AKY, Lok HT, Fong AKW, Chong CCN, Lai PBS.

Hepatobiliary Surg Nutr. 2018 Jun;7(3):185-188. doi: 10.21037/hbsn.2017.05.12. No abstract available.

32.

Loss of tumor suppressor IGFBP4 drives epigenetic reprogramming in hepatic carcinogenesis.

Lee YY, Mok MT, Kang W, Yang W, Tang W, Wu F, Xu L, Yan M, Yu Z, Lee SD, Tong JHM, Cheung YS, Lai PBS, Yu DY, Wang Q, Wong GLH, Chan AM, Yip KY, To KF, Cheng ASL.

Nucleic Acids Res. 2018 Sep 28;46(17):8832-8847. doi: 10.1093/nar/gky589.

33.

Systematic review and meta-analysis of robotic versus open hepatectomy.

Wong DJ, Wong MJ, Choi GH, Wu YM, Lai PB, Goh BKP.

ANZ J Surg. 2019 Mar;89(3):165-170. doi: 10.1111/ans.14690. Epub 2018 Jun 26. Review.

PMID:
29943881
34.

Liver- and Colon-Specific DNA Methylation Markers in Plasma for Investigation of Colorectal Cancers with or without Liver Metastases.

Gai W, Ji L, Lam WKJ, Sun K, Jiang P, Chan AWH, Wong J, Lai PBS, Ng SSM, Ma BBY, Wong GLH, Wong VWS, Chan HLY, Chiu RWK, Lo YMD, Chan KCA.

Clin Chem. 2018 Aug;64(8):1239-1249. doi: 10.1373/clinchem.2018.290304. Epub 2018 Jun 14.

PMID:
29903871
35.

Does Intermittent Pringle Maneuver Increase Postoperative Complications After Hepatectomy for Hepatocellular Carcinoma? A Randomized Controlled Trial.

Lee KF, Wong J, Cheung SYS, Chong CCN, Hui JWY, Leung VYF, Yu SCH, Lai PBS.

World J Surg. 2018 Oct;42(10):3302-3311. doi: 10.1007/s00268-018-4637-3.

PMID:
29696328
36.

Squalene epoxidase drives NAFLD-induced hepatocellular carcinoma and is a pharmaceutical target.

Liu D, Wong CC, Fu L, Chen H, Zhao L, Li C, Zhou Y, Zhang Y, Xu W, Yang Y, Wu B, Cheng G, Lai PB, Wong N, Sung JJY, Yu J.

Sci Transl Med. 2018 Apr 18;10(437). pii: eaap9840. doi: 10.1126/scitranslmed.aap9840. Erratum in: Sci Transl Med. 2018 Sep 26;10(460):.

PMID:
29669855
37.

Reduction of operative mortality after implementation of Surgical Outcomes Monitoring and Improvement Programme by Hong Kong Hospital Authority.

Yuen WC, Wong K, Cheung YS, Lai PB.

Hong Kong Med J. 2018 Apr;24(2):137-144. doi: 10.12809/hkmj177118. Epub 2018 Apr 6.

38.

EUS-FNA using 22G nitinol or ProCore needles without on-site cytopathology.

Chong CCN, Teoh AYB, Tang RSY, Chan AWH, Ng EKW, Lai PBS.

Endosc Ultrasound. 2018 Jan-Feb;7(1):56-60. doi: 10.4103/eus.eus_113_17.

39.

Hypermethylation of NF-κB-Activating Protein-Like (NKAPL) Promoter in Hepatocellular Carcinoma Suppresses Its Expression and Predicts a Poor Prognosis.

Ng PKS, Lau CPY, Lam EKY, Li SSK, Lui VWY, Yeo W, Ng YK, Lai PBS, Tsui SKW.

Dig Dis Sci. 2018 Mar;63(3):676-686. doi: 10.1007/s10620-018-4929-3. Epub 2018 Jan 20.

PMID:
29353445
40.

Microwave ablation provides better survival than liver resection for hepatocellular carcinoma in patients with borderline liver function: application of ALBI score to patient selection.

Chong CCN, Lee KF, Chu CM, Chan AWH, Wong J, Chan SL, Lok HT, Fung AKY, Fong AKW, Cheung YS, Yu SCH, Johnson P, Lai PBS.

HPB (Oxford). 2018 Jun;20(6):546-554. doi: 10.1016/j.hpb.2017.12.001. Epub 2018 Jan 17.

41.

Circulating Tumor Cells from Different Vascular Sites Exhibit Spatial Heterogeneity in Epithelial and Mesenchymal Composition and Distinct Clinical Significance in Hepatocellular Carcinoma.

Sun YF, Guo W, Xu Y, Shi YH, Gong ZJ, Ji Y, Du M, Zhang X, Hu B, Huang A, Chen GG, Lai PBS, Cao Y, Qiu SJ, Zhou J, Yang XR, Fan J.

Clin Cancer Res. 2018 Feb 1;24(3):547-559. doi: 10.1158/1078-0432.CCR-17-1063. Epub 2017 Oct 25.

42.

New insights into sorafenib resistance in hepatocellular carcinoma: Responsible mechanisms and promising strategies.

Niu L, Liu L, Yang S, Ren J, Lai PBS, Chen GG.

Biochim Biophys Acta Rev Cancer. 2017 Dec;1868(2):564-570. doi: 10.1016/j.bbcan.2017.10.002. Epub 2017 Oct 17. Review.

PMID:
29054475
43.

Hepatoma-intrinsic CCRK inhibition diminishes myeloid-derived suppressor cell immunosuppression and enhances immune-checkpoint blockade efficacy.

Zhou J, Liu M, Sun H, Feng Y, Xu L, Chan AWH, Tong JH, Wong J, Chong CCN, Lai PBS, Wang HK, Tsang SW, Goodwin T, Liu R, Huang L, Chen Z, Sung JJ, Chow KL, To KF, Cheng AS.

Gut. 2018 May;67(5):931-944. doi: 10.1136/gutjnl-2017-314032. Epub 2017 Sep 22.

44.

The CCCTC-binding factor (CTCF)-forkhead box protein M1 axis regulates tumour growth and metastasis in hepatocellular carcinoma.

Zhang B, Zhang Y, Zou X, Chan AW, Zhang R, Lee TK, Liu H, Lau EY, Ho NP, Lai PB, Cheung YS, To KF, Wong HK, Choy KW, Keng VW, Chow LM, Chan KK, Cheng AS, Ko BC.

J Pathol. 2017 Dec;243(4):418-430. doi: 10.1002/path.4976. Epub 2017 Oct 27.

45.

Albumin-bilirubin grade predicts the outcomes of liver resection versus radiofrequency ablation for very early/early stage of hepatocellular carcinoma.

Chong CC, Chan AW, Wong J, Chu CM, Chan SL, Lee KF, Yu SC, To KF, Johnson P, Lai PB.

Surgeon. 2018 Jun;16(3):163-170. doi: 10.1016/j.surge.2017.07.003. Epub 2017 Aug 12.

PMID:
28807570
46.

Electroacupuncture-reduced sedative and analgesic requirements for diagnostic EUS: a prospective, randomized, double-blinded, sham-controlled study.

Teoh AYB, Chong CCN, Leung WW, Chan SKC, Tse YK, Ng EKW, Lai PBS, Wu JCY, Lau JYW.

Gastrointest Endosc. 2018 Feb;87(2):476-485. doi: 10.1016/j.gie.2017.07.029. Epub 2017 Jul 24.

PMID:
28750840
47.

Interactome and reciprocal activation of pathways in topical mesenchymal stem cells and the recipient cerebral cortex following traumatic brain injury.

Lam PK, Wang KKW, Lo AWI, Tong CSW, Ching DWC, Wong K, Yang Z, Kong T, Lo KKY, Choy RKW, Lai PBS, Wong GKC, Poon WS.

Sci Rep. 2017 Jul 10;7(1):5017. doi: 10.1038/s41598-017-01772-7.

48.

A phase 2 study of the efficacy and biomarker on the combination of transarterial chemoembolization and axitinib in the treatment of inoperable hepatocellular carcinoma.

Chan SL, Yeo W, Mo F, Chan AWH, Koh J, Li L, Hui EP, Chong CCN, Lai PBS, Mok TSK, Yu SCH.

Cancer. 2017 Oct 15;123(20):3977-3985. doi: 10.1002/cncr.30825. Epub 2017 Jun 22.

49.

Topical Application of Mesenchymal Stromal Cells Ameliorated Liver Parenchyma Damage After Ischemia-Reperfusion Injury in an Animal Model.

Lam PK, Chong CCN, Lo AWI, Chan AWH, Tong CSW, Chin DWC, Wong KHK, Choy RKW, Fung AK, Wang YX, To KF, Lai PBS.

Transplant Direct. 2017 May 11;3(6):e160. doi: 10.1097/TXD.0000000000000675. eCollection 2017 Jun.

50.

A new VLAD-based control chart for detecting surgical outcomes.

Yue J, Lai X, Liu L, Lai PBS.

Stat Med. 2017 Dec 10;36(28):4540-4547. doi: 10.1002/sim.7362. Epub 2017 Jun 7.

PMID:
28589642

Supplemental Content

Support Center